Ignite Creation Date:
2024-05-06 @ 1:13 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03969121
Status:
COMPLETED
Last Update Posted:
2023-03-10
First Post:
2019-05-13
Brief Title:
Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable Hormone Sensitive and HER2-Negative Primary Breast Cancer
Sponsor:
Kyoto Breast Cancer Research Network
Organization:
Kyoto Breast Cancer Research Network
Organization Data
Organization:
Kyoto Breast Cancer Research Network
Class:
OTHER
Study ID:
OOTR-N016KBCRN-B-003HT-PAB
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kyoto Breast Cancer Research Network
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |